The mechanisms contributing to increased expression of CX3CR1 in hypoxic conditions may involve HIF-1-dependent and NF-κB-dependent signaling pathways, as shown in prostate cancer cells [40]. The gene discussed is NFKB1; the disease is prostate carcinoma.